BCL2L1 and glioblastoma: Data presented here regarding the anti-GBM effect of 5-AcTMF primarily focused on proapoptotic action of 5-AcTMF on GBM cells due to impairing the antiapoptotic STAT3-BCL-2/BCL-xL signaling axis.